Myhep LVIR Sofosbuvir 400mg + Ledipasvir 90mg
Myhep Lvir used in Treating chronic hepatitis C virus (HCV) infection in certain patients. Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
How it works
Myhep LVIR Sofosbuvir 400mg + Ledipasvir 90mg works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Side Effects of MYHEP LVIR TABLET:
Side effects of sofosbuvir used in combination with ledipasvir they include tiredness and headache nausea, difficulty sleeping, and low red blood cell count.
Special Precautions for MYHEP LVIR TABLET:
Bradycardia with amiodarone coadministration:
Serious symptomatic bradycardia may occur in patients taking amiodarone and sofosbuvir in combination with another direct acting antiviral (daa), particularly in patients also receiving beta blockers, or those with underlying cardiac comorbidities and/or advanced liver disease. Coadministration of amiodarone with sofosbuvir in combination with another daa is not recommended.
Ribavirin may cause birth defects and fetal death and animal studies have shown interferons have abortifacient effects; avoid pregnancy in female patients and female partners of male patients. Patients must have a negative pregnancy test prior to initiating therapy.
|Minimum Order Quantity||3 Bottle|
|Strength/Dose (in mg or ml)||90 mg Ledipasvir and 400 mg sofosbuvir|
|Pack Size||28 Tablets|
|Product Type||Finish Product|
Myhep Lvir is a prescription drug and should be used under proper medical guidance and advice.
Ledipasvir Sofosbuvir Details:
- Brand name: MyHep LVIR
- Contents : Ledipasvir and Sofosbuvir
- Form: Tablets
- Strength: Ledipasvir 90 mg Sofosbuvir 400 mg
- Packing: Pack of 28 tablets